APA (7th ed.) Citation

Liu, Z., Li, Y., & Long, X. (2025). A Promising Breakthrough for Triple‐Negative Breast Cancer by Targeting the AKT and EZH2. MedComm (2020), 6(8), e70318-n/a. https://doi.org/10.1002/mco2.70318

Chicago Style (17th ed.) Citation

Liu, Zhuoyun, Yirong Li, and Xinghua Long. "A Promising Breakthrough for Triple‐Negative Breast Cancer by Targeting the AKT and EZH2." MedComm (2020) 6, no. 8 (2025): e70318-n/a. https://doi.org/10.1002/mco2.70318.

MLA (9th ed.) Citation

Liu, Zhuoyun, et al. "A Promising Breakthrough for Triple‐Negative Breast Cancer by Targeting the AKT and EZH2." MedComm (2020), vol. 6, no. 8, 2025, pp. e70318-n/a, https://doi.org/10.1002/mco2.70318.